Plasma exosomal miR-199a-3p downregulates cell proliferation and migration in Hirschsprung's disease by targeting

Yu Daiyue1, Yang Yang1, Huang Zhaorong1

  • 1Department of Pediatric Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou, 510282, Guangdong, China.

Abstract

Insights

Plasma exosomal miR-199a-3p is upregulated in Hirschsprung's disease (HSCR) and inhibits cell growth by targeting mTOR. This microRNA is a potential diagnostic marker and therapeutic target for HSCR.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Genetics

Background:

  • Plasma exosomal microRNAs are potential disease biomarkers.
  • Exosomal microRNAs in Hirschsprung's disease (HSCR) remain largely uncharacterized.
  • This study investigates miR-199a-3p in HSCR pathogenesis.

Purpose of the Study:

  • To analyze miRNA profiles in HSCR.
  • To elucidate the mechanism of miR-199a-3p in HSCR development.
  • To identify potential diagnostic biomarkers for HSCR.

Main Methods:

  • Plasma exosome isolation and miRNA sequencing.
  • Cell proliferation and migration assays (CCK-8, Transwell).
  • Bioinformatic analysis (GO, KEGG, PPI) and target validation (PCR, Western blot) for miR-199a-3p and mTOR.

Main Results:

  • miR-199a-3p was upregulated in plasma exosomes and HSCR tissues.
  • miR-199a-3p inhibited cell proliferation and migration in vitro.
  • mTOR was identified as a target of miR-199a-3p, showing downregulation and a negative correlation in HSCR tissues. mTOR partially reversed miR-199a-3p's effects.

Conclusions:

  • miR-199a-3p suppresses cell growth and motility by targeting mTOR.
  • Plasma exosomal miR-199a-3p is a crucial diagnostic marker for HSCR.
  • miR-199a-3p represents a potential therapeutic target for HSCR.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.5K